ACUTE-PHASE EFFICACY OF ZS-9 IN PATIENTS WITH BASELINE SERUM POTASSIUM LEVELS ABOVE 5.5 MEQ/L: ANALYSIS FROM A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL

ACUTE-PHASE EFFICACY OF ZS-9 IN PATIENTS WITH BASELINE SERUM POTASSIUM LEVELS ABOVE 5.5 MEQ/L: ANALYSIS FROM A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL

Here we report acute-phase efficacy in patients with baseline K+ >5.5 mEq/L from a large, randomized, placebo-controlled Phase 3 trial.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2015-03, Vol.65 (10), p.A878-A878
Hauptverfasser: El-Shahawy, Mohamed, Rasmussen, Henrik S, Lavin, Philip T, Yang, Alex, Packham, David K
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Cardiovascular
Internal Medicine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Here we report acute-phase efficacy in patients with baseline K+ >5.5 mEq/L from a large, randomized, placebo-controlled Phase 3 trial.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(15)60878-6